Your browser doesn't support javascript.
loading
Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic pain.
Al Mukhaizeem, Sammy; Nasa, Anurag; Waldron, Dympna; McDaid, Alex; Gorman, Patrick J; Featherstone, Molly; Barry, Megan; Murphy, Paul; Gallagher, Hugh; Nair, Shrijit; O'Connor, Michael; Kelly, Linda; O'Hora, Emma; Dolan, Roisin; Mac Colgain, Siaghal; McGrath, Jack; Blouin, Stephane; Roman, Elena; Gaffney, Laura; Roddy, Darren William; Levins, Kirk John.
Afiliação
  • Al Mukhaizeem S; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Nasa A; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • Waldron D; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • McDaid A; Department of Psychiatry, Education and Research Centre, Royal College of Surgeons, Beaumont Hosptial, Dublin, Ireland.
  • Gorman PJ; Department of Palliative Medicine, Saolta Hospitals Group, Galway University Hospital, Galway, Ireland.
  • Featherstone M; Department of Medicine, University of Galway, Galway, Ireland.
  • Barry M; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Murphy P; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • Gallagher H; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Nair S; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • O'Connor M; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Kelly L; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • O'Hora E; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Dolan R; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • Mac Colgain S; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • McGrath J; School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin, Ireland.
  • Blouin S; SPIRIT (St Vincent's Pain Institute: Research, Innovation and Therapies), St Vincent's University Hospital, Dublin, Ireland.
  • Roman E; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Gaffney L; Department of Anaesthesia, St Vincent's University Hospital, Dublin, Ireland.
  • Roddy DW; Department of Psychiatry, Education and Research Centre, Royal College of Surgeons, Beaumont Hosptial, Dublin, Ireland.
  • Levins KJ; Department of Psychiatry, Education and Research Centre, Royal College of Surgeons, Beaumont Hosptial, Dublin, Ireland.
Front Pain Res (Lausanne) ; 4: 1268985, 2023.
Article em En | MEDLINE | ID: mdl-38077652
ABSTRACT

Introduction:

Chronic pain is defined as pain lasting longer than 3 months. This often causes persistent emotional distress and functional disability that is refractory to conventional treatments. Emerging evidence suggests that oral Ketamine therapy may have a specific role in managing treatment-resistant chronic pain. This study aimed to assess the effectiveness of oral ketamine within a tertiary chronic pain management clinic.

Methods:

This study was a clinic-based retrospective descriptive study of 79 patients with a broad range of chronic pain diagnoses and treated with oral ketamine over a period up to 12 years. Changes in pain, mood and quality of life (QoL) were assessed using a numerical pain severity score, the Brief Pain Inventory (BPI), the Public Health Questionnaire (PHQ-9) and American Chronic Pain Association Quality of Life (QoL) scale.

Results:

73 patients were accessible for follow-up (mean daily dose and treatment duration were 193.84 mg and 22.6 months respectively). Pain scores decreased (p < 0.0001) on both numerical scores (41.6% decrease) and BPI scoring (mean decrease 2.61). Mood improved (p < 0.0001) across both PHQ-9 and BPI measurements. Patients also reported less difficulty with daily activities and improved QoL. The most common adverse reaction was drowsiness (21.9%), with 30.1% reporting no adverse reactions from Ketamine.

Discussion:

This work adds to the growing body of evidence that under the supervision of a pain specialist, oral ketamine therapy may be a safe, tolerable and effective treatment for chronic pain conditions which have not responded to other management options. Further research is required to produce a more accurate understanding of its chronic use. Key message This real-world study shows that patients being treated with oral ketamine for chronic pain report decreased severity of pain, improved mood and increased quality of life across all conditions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article